• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Themis Medicare Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
530199
INE083B01024
29.0964672
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
THEMISMED
0
960.14
EPS(TTM)
Face Value()
Div & Yield %
0
1
0.48
 

HEG plunges after net loss widens to Rs 114 cr in Q4 FY26
Apr 30,2026
Despite the weak bottom line, revenue from operations jumped 12.42% YoY to Rs 603.21 crore in Q4 FY26.

The company reported pre-tax loss of Rs 144.94 crore in Q4 FY26, compared with pre-tax loss of Rs 79.76 crore in the corresponding quarter of the previous fiscal.

Total expenses climbed 24.62% YoY to Rs 814.81 crore during the quarter. Cost of material consumed stood at Rs 260.51 crore (up 6.97% YoY), employee benefit expenses was at Rs 35.34 crore (up 40.63% YoY), power and Fuel expenses stood at Rs 93.03 crore (up 18.71% YoY) while finance cost was at Rs 10.72 crore (down 10.74% YoY) during the period under review.

In Q4 FY26, revenue from graphite segment jumped 12.04% YoY to Rs 589.61 crore while revenue from power segment declined 39.57% YoY to Rs 6.23 crore

Meanwhile, the company’s board recommended a final dividend on equity shares at Rs 3.40 per equity share of the face value of Rs 2 each for the financial year 2025-26.

HEG is India's leading graphite electrode manufacturer. It has one of the largest integrated graphite electrode plants in the world, processing sophisticated UHP (ultra high power) electrodes.